That is assuming CHF has such finances. No one is stopping him from converting those warrants. My belief is they haven't been able to get financing to close the deal; and AMBS convertible note holders are refusing to settle for a steep discount. Thus the deal is not as appetizing to SED as it first appeared.
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links